HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emily Barker Selected Research

25-hydroxyvitamin D

10/201825-hydroxyvitamin D serum levels in patients with high risk resected melanoma treated in an adjuvant bevacizumab trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Emily Barker Research Topics

Disease

3Infections
01/2023 - 03/2011
2Retained Placenta
01/2023 - 06/2022
2Hemorrhage
01/2023 - 06/2022
1Uterine Rupture
01/2023
1Premature Obstetric Labor (Premature Labor)
01/2023
1Congenital Abnormalities (Deformity)
06/2022
1Neoplasms (Cancer)
01/2020
1Melanoma (Melanoma, Malignant)
10/2018

Drug/Important Bio-Agent (IBA)

1Misoprostol (Cytotec)FDA LinkGeneric
01/2023
1Mifepristone (RU 486)FDA Link
06/2022
1DNA (Deoxyribonucleic Acid)IBA
01/2020
125-hydroxyvitamin DIBA
10/2018
1Bevacizumab (Avastin)FDA Link
10/2018
1Vitamin DFDA LinkGeneric
10/2018
1Panton-Valentine leukocidinIBA
03/2011

Therapy/Procedure

1Blood Transfusion (Blood Transfusions)
01/2023
1Curettage
06/2022